AAAAAA
Results: 26-43/43
Authors:
Reiter, A
Schrappe, M
Ludwig, WD
Tiemann, M
Parwaresch, R
Zimmermann, M
Schirg, E
Henze, G
Schellong, G
Gadner, H
Riehm, H
Citation: A. Reiter et al., Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM Groupreport, BLOOD, 95(2), 2000, pp. 416-421
Authors:
Rudolph, P
Schubert, C
Tamm, S
Heidorn, K
Hauschild, A
Michalska, I
Majewski, S
Krupp, G
Jablonska, S
Parwaresch, R
Citation: P. Rudolph et al., Telomerase activity in melanocytic lesions - A potential marker of tumor biology, AM J PATH, 156(4), 2000, pp. 1425-1432
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer
Authors:
Rudolph, P
Alm, P
Heidebrecht, HJ
Bolte, H
Ratjen, V
Baldetorp, B
Ferno, M
Olsson, H
Parwaresch, R
Citation: P. Rudolph et al., Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer, J NAT CANC, 91(3), 1999, pp. 271-278
Authors:
Singh, KK
Parwaresch, R
Krupp, G
Citation: Kk. Singh et al., Rapid kinetic characterization of hammerhead ribozymes by real-time monitoring of fluorescence resonance energy transfer (FRET), RNA, 5(10), 1999, pp. 1348-1356
Authors:
Kuropkat, C
Rudolph, P
Frahm, SO
Parwaresch, R
Werner, JA
Citation: C. Kuropkat et al., Proliferation marker Ki-S11 - a prognostic indicator for squamous cell carcinoma of the hypopharynx, VIRCHOWS AR, 435(6), 1999, pp. 590-595
Authors:
Felgner, J
Heidorn, K
Korbacher, D
Frahm, SO
Parwaresch, R
Citation: J. Felgner et al., Cell lineage specificity in G-CSF receptor gene methylation, LEUKEMIA, 13(4), 1999, pp. 530-534
Authors:
Salmassi, A
Mettler, L
Wolf, H
Mantwill, K
Sabzeghabai, M
Parwaresch, R
Citation: A. Salmassi et al., Characterization of a MAb to ovarian cancer and its possible diagnostic application, EUR J GYN O, 20(4), 1999, pp. 289-297
Authors:
Bonatz, G
Luttes, J
Hamann, S
Mettler, L
Jonat, W
Parwaresch, R
Citation: G. Bonatz et al., Immunohistochemical assessment of p170 provides prognostic information in endometrial carcinoma, HISTOPATHOL, 34(1), 1999, pp. 43-50
Authors:
Zhang, Y
Heidebrecht, HJ
Rott, A
Schlegelberger, B
Parwaresch, R
Citation: Y. Zhang et al., Assignment of human proliferation associated p100 gene (C20orf1) to human chromosome band 20q11.2 by in situ hybridization, CYTOG C GEN, 84(3-4), 1999, pp. 182-183
Authors:
Rudolph, P
Schubert, C
Zelger, BG
Zelger, B
Parwaresch, R
Citation: P. Rudolph et al., Differential expression of CD34 and Ki-M1p in pleomorphic fibroma and dermatofibroma with monster cells, AM J DERMAT, 21(5), 1999, pp. 414-419
Authors:
Rudolph, P
MacGrogan, G
Bonichon, F
Frahm, SO
de Mascarel, I
Trojani, M
Durand, M
Avril, A
Coindre, JM
Parwaresch, R
Citation: P. Rudolph et al., Prognostic significance of Ki-67 and topoisomerase II alpha expression in infiltrating ductal carcinoma of the breast - A multivariate analysis of 863 cases, BREAST CANC, 55(1), 1999, pp. 61-71
Authors:
Bonatz, G
Luttges, J
Hedderich, J
Jonat, W
Rudolph, P
Parwaresch, R
Citation: G. Bonatz et al., Prognostic significance of a novel proliferation marker, anti-repp 86, forendometrial carcinoma: A multivariate study, HUMAN PATH, 30(8), 1999, pp. 949-956
Authors:
Fandrich, F
Lin, X
Huang, DS
Zhu, X
Parwaresch, R
Kremer, B
Henne-Bruns, D
Citation: F. Fandrich et al., Thymic and liver graft expression of CD95-L tolerizes allogeneic orthotopic liver grafts, TRANSPLAN P, 31(1-2), 1999, pp. 438-439
Authors:
Rudolph, P
Olsson, H
Bonatz, G
Ratjen, V
Bolte, H
Baldetorp, B
Ferno, M
Parwaresch, R
Alm, P
Citation: P. Rudolph et al., Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negativebreast carcinomas: Prognostic implications, J PATHOLOGY, 187(2), 1999, pp. 207-216
Authors:
Frahm, SO
Rudolph, P
Dworeck, C
Zott, B
Heidebrecht, H
Steinmann, J
Neppert, J
Parwaresch, R
Citation: So. Frahm et al., Immunoenzymatic detection of the new proliferation associated protein p100by means of a cellular ELISA: specific detection of cells in cell cycle phases S, G2 and M, J IMMUNOL M, 223(2), 1999, pp. 147-153
Authors:
Rudolph, P
Kellner, U
Schmidt, D
Kirchner, V
Talerman, A
Harms, D
Parwaresch, R
Citation: P. Rudolph et al., Ki-A10, a germ cell nuclear antigen retained in a subset of germ cell-derived tumors, AM J PATH, 154(3), 1999, pp. 795-803
Authors:
Rudolph, P
Tronnier, M
Menzel, R
Moller, M
Parwaresch, R
Citation: P. Rudolph et al., Enhanced expression of Ki-67, topoisomerase II alpha, PCNA, p53 and p21(WAF1/Cip1) reflecting proliferation and repair activity in UV-irradiated melanocytic nevi, HUMAN PATH, 29(12), 1998, pp. 1480-1487
Authors:
Bonatz, G
Klapper, W
Barthe, A
Heidorn, K
Jonat, W
Krupp, G
Parwaresch, R
Citation: G. Bonatz et al., Analysis of telomerase expression and proliferative activity in the different layers of cyclic endometrium, BIOC BIOP R, 253(2), 1998, pp. 214-221